Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Neuroblastoma 1

Interventions

Temozolomide 147 Radiotherapy 90 Cyclophosphamide 53 Magnetic Resonance Spectroscopy 42 Radiation 41 Bevacizumab 38 Irinotecan 34 Filgrastim 29 Radiosurgery 26 Specimen Handling 25 Nivolumab 25 Carboplatin 24 Topotecan 23 Etoposide 22 fludarabine 20 Surgical Procedures, Operative 20 pembrolizumab 18 Vorinostat 18 Vincristine 18 Melphalan 17 Granulocyte Colony-Stimulating Factor 17 sargramostim 15 Peripheral Blood Stem Cell Transplantation 14 Ipilimumab 14 Drug Therapy 13 temsirolimus 12 Sirolimus 12 Radiotherapy, Intensity-Modulated 12 O(6)-benzylguanine 12 Everolimus 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Tissue Banks × CNS × Clear all

NCT04239040 2025-03-19

GVAX Plus Checkpoint Blockade in Neuroblastoma

Dana-Farber Cancer Institute

Phase 1 Terminated

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡